Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
27,995,500
-
Total 13F shares
-
15,877,766
-
Share change
-
+749,273
-
Total reported value
-
$154,493,194
-
Put/Call ratio
-
6300%
-
Price per share
-
$9.73
-
Number of holders
-
68
-
Value change
-
+$4,671,125
-
Number of buys
-
41
-
Number of sells
-
31
Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q4 2017
As of 31 Dec 2017,
Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,877,766 shares.
The largest 10 holders included
FMR LLC, Flagship Pioneering Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WELLINGTON MANAGEMENT GROUP LLP, ARK Investment Management LLC, Redmile Group, LLC, Vanguard Group Inc, BlackRock Inc., BAKER BROS. ADVISORS LP, and Aisling Capital LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.